Loading...
XSHE
002584
Market cap786mUSD
Jul 10, Last price  
8.76CNY
1D
-3.95%
1Q
12.89%
IPO
62.91%
Name

Xilong Scientific Co Ltd

Chart & Performance

D1W1MN
XSHE:002584 chart
P/E
—
P/S
0.70
EPS
—
Div Yield, %
0.22%
Shrs. gr., 5y
1.67%
Rev. gr., 5y
6.38%
Revenues
7.33b
-6.21%
766,705,162881,978,0261,164,155,3331,281,031,3961,544,721,1532,239,893,3532,197,935,7862,513,529,3152,928,383,5073,305,218,5303,355,078,3563,337,661,9616,243,170,9326,837,667,6335,379,903,5926,183,208,8126,183,208,8117,091,743,4117,816,465,7937,330,854,726
Net income
-75m
L
46,703,43057,278,75872,894,39782,278,61964,301,63448,607,49777,528,17290,793,42896,789,60789,845,69570,577,61138,527,21856,873,467187,064,486187,064,49389,063,74589,063,75033,347,83061,773,373-75,489,545
CFO
69m
-77.04%
35,245,67049,543,76640,155,818013,554,37732,283,126104,508,649128,791,42711,002,0350095,892,72944,571,222346,617,6470-284,714,593302,163,80769,364,674
Dividend
Dec 23, 20240.033 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Xilong Scientific Co., Ltd. is a Chinese enterprise primarily engaged in the research, development, manufacturing, and distribution of chemical reagents. Its comprehensive product portfolio encompasses a wide array of specialized chemicals, including general chemical reagents, high-purity reagents, and those specifically for Printed Circuit Boards (PCB). Furthermore, the company supplies food additives, active pharmaceutical and chemical materials, and various lab glassware products. Beyond its domestic operations in China, Xilong Scientific also extends its market reach through product exports. Established in 1983 and headquartered in Shantou, China, the company underwent a name change in December 2015, transitioning from its former identity as Xilong Chemical Co., Ltd.
URL
http://www.xilongs.com/
IPO date
Jun 02, 2011
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT